Condition 1: Unexplained infertility. Condition 2: Male factor infertility. Female infertility, unspecified Oligospermia NOS
Conditions
Interventions
Intervention 1: Ovarian cycle stimulation was started on the 3rd day of menstruation after the basal transvaginal ultrasound (TV-USG) with 100 mg CC for 5 consecutive days.The gonadotropin regimens ad
Treatment - Drugs
Ovarian cycle stimulation was started on the 3rd day of menstruation after the basal transvaginal ultrasound (TV-USG) with 100 mg CC for 5 consecutive days.The gonadotropin regimens adopted in each gr
Ovarian cycle stimulation was started on the 3rd day of menstruation after the basal transvaginal ultrasound (TV-USG) with 100 mg CC for 5 consecutive days.The gonadotropin regimens adopted was rFSH 7
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: history of infertility of more than 1 year; wemon's age between 20 and 40 years old; documentation of normal ovulatory cycles; normal TSH and Prolactin level; normal reproductive hormones in the early follicular phase;patent tubes have been shown by HSG or laparoscopy; normal sperm count, motility and morphology according to the World Health Organization criteria(WHO 1992)in unexplained infertility and total motile sperm count more than 1 million in male factor infertility.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate. Timepoint: 7 weeks of gestation. Method of measurement: Fetal heart activity with ultrasound.;Ongoing pregnancy rate. Timepoint: 12 weeks of gestation. Method of measurement: Fetal heart activity with ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean of follicular size on the day of HCG administration. Timepoint: Day of occurrence of at least one ovarian follicule =16 mm in diameter. Method of measurement: Ultrasound.;Endometrial thickness on the day of HCG administration. Timepoint: Day of occurrence of at least one ovarian follicule =16 mm in diameter. Method of measurement: Ultrasound.;Total dose of gonadotropin. Timepoint: Day of occurrence of at least one ovarian follicule =16 mm in diameter. Method of measurement: Number of vials.;Duration of stimulation with gonadotropin. Timepoint: Day of occurrence of at least one ovarian follicule =16 mm in diameter. Method of measurement: Number of days gonadotropin was administered.;Number of dominant follicles on the day of HCG administration. Timepoint: Day of occurrence of at least one ovarian follicule =16 mm in diameter. Method of measurement: Number of dominant follicles. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Bahrami
Semnan University of Medical Sciences
Outcome results
None listed